Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 37 for Chronic progressive multiple sclerosis
  1. Dementia 
    ... to dementia: Huntington disease Brain injury Frontotemporal ... (chronic) alcohol abuse Changes in blood sugar, sodium, and ...
    https://medlineplus.gov/ency/article/000739.htm - Medical Encyclopedia
  2. Guide for Support Partners (National Multiple Sclerosis Society) - PDF  
    Multiple Sclerosis/Related Issues ... Multiple Sclerosis ... Caregivers/Specifics ... Caregivers ... National Multiple Sclerosis Society ... PDF
    https://cdn.sanity.io/...ecdc13c9d92b721ef4b0be3dc8d14f20f5868f6.pdf - External Health Links
  3. Alemtuzumab Injection (Multiple Sclerosis) 
    ... only gives information about alemtuzumab injection (Lemtrada) for multiple sclerosis. If you are receiving alemtuzumab for chronic lymphocytic leukemia, read the monograph entitled Alemtuzumab Injection ( ...
    https://medlineplus.gov/druginfo/meds/a619012.html - Drugs and Supplements
  4. Ofatumumab Injection (Multiple Sclerosis) 
    ... only gives information about ofatumumab injection (Kesimpta) for multiple sclerosis. If you are receiving ofatumumab for chronic lymphocytic leukemia, read the monograph entitled Ofatumumab Injection ( ...
    https://medlineplus.gov/druginfo/meds/a621050.html - Drugs and Supplements
  5. Ofatumumab Injection (Chronic Lymphocytic Leukemia) 
    ... information about ofatumumab injection (Arzerra) for treatment of chronic lymphocytic leukemia. If you are receiving ofatumumab for multiple sclerosis, read the monograph entitled Ofatumumab Injection (Multiple Sclerosis).
    https://medlineplus.gov/druginfo/meds/a610009.html - Drugs and Supplements
  6. Sleep Disorders: What You Need To Know From the National Institutes of Health (National Center for Complementary and Integrative Health)  
    Sleep Disorders/Treatments and Therapies ... Sleep Disorders ... Insomnia/Treatments and Therapies ... Insomnia ... National Center for Complementary and Integrative Health
    https://www.nccih.nih.gov/.../sleep-disorders-what-you-need-to-know - External Health Links
  7. How Does Rehabilitative Technology Benefit People with Disabilities? From the National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development)  
    Assistive Devices/Learn More ... Assistive Devices ... Eunice Kennedy Shriver National Institute of Child Health and Human Development ... From the National Institutes ...
    https://www.nichd.nih.gov/health/topics/rehabtech/conditioninfo/help - External Health Links
  8. New NIH study may help predict those at risk for severe MS | NIH MedlinePlus Magazine 
    ... What you need to know What is MS? Multiple sclerosis, or MS, is a chronic disease that affects the central nervous system (the brain and... Multiple Sclerosis Uncovering the mysteries of multiple sclerosis An estimated ...
    https://magazine.medlineplus.gov/...dict-those-at-risk-for-severe-ms - MedlinePlus Magazine
  9. Dimethyl Fumarate 
    ... flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Dimethyl fumarate is in a class of medications called Nrf2 activators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
    https://medlineplus.gov/druginfo/meds/a613028.html - Drugs and Supplements
  10. Diroximel Fumarate 
    ... flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Diroximel fumarate is in a class of medications called Nrf2 activators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
    https://medlineplus.gov/druginfo/meds/a620002.html - Drugs and Supplements
previous · 1 · 2 · 3 · 4 · next